Pharmacologic Treatment AHF Flashcards

1
Q

VMAC

A

Nesiritide vs NTG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

optiME

A

MElrinone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

VeriTEZ

A

TEZosentan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

surVive

A

LeVosimendan vs dobu

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

3CPO

A

NIV vs CPAP vs O2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

pRotect

A

Rolofylline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

asceNd

A

Nesiritide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

RELAX

A

seRELAXin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

reVive

A

LeVosimendan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Enalapril HF

A

consEnsus,, soLvd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Captopril MI

A

SAVE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Ramipril MI

A

AIRE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

TRandolapril

A

TRace

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

VALsartan HF

A

VAL heft

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Candesartan HF

A

Charm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Losartan HF

A

HEEAL , High dose losartan not associated with reduction of outcomes

17
Q

Spironolactone HF

A

raleS

18
Q

Eplerenone HF

A

EMPHASIS

19
Q

Eplerenone MI

A

Ephesus

20
Q

Bisoprolol

A

CiBIs

21
Q

Carvedilol HF

A

Copernicus, Carvedilol

22
Q

Metoprolol

A

Merit HF

23
Q

Carvedilol MI

A

Capricorn

24
Q

ELITE II

A

Losartan not associated with improved survival

25
Q

VALIANT

A

Losartan not as effective as Captopril

26
Q

COMET

A

Carvedilol is superior than Metoprolol Tartrate

Met tartrate should not be used in HF

27
Q

SENIORS

A

Nebivolol reduced outcomes but not mortality

28
Q

B CONVINCED

A

Beta blocker may be continued during acute decompensation

29
Q

SHIFT

A

Ivabradine did not meet primary end point in CAD and LVD